BCI
PFE icon

Blue Capital Inc’s Pfizer PFE Stock Holding History

Blue Capital Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$273K Buy
9,734
+1,068
+12% +$28.4K 0.18% 88
2025
Q4 		$216K Buy
+8,666
New +$219K 0.15% 83
2024
Q4 		$595K Buy
+22,444
New +$609K 0.42% 66

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Blue Capital Inc's PFE Position: Q1 2026 in Review

Blue Capital Inc increased its Pfizer (PFE) stake by 12% in Q1 2026, buying an estimated $28.4K and bringing the position to 9,734 shares worth $273K. The position accounts for 0.18% of the portfolio, ranked #88.

Blue Capital Inc first reported a position in PFE in Q4 2024 and has held it in 3 quarters since. The position peaked at $595K in Q4 2024. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Blue Capital Inc held 9,734 shares of Pfizer worth $273K as of Q1 2026.
  • Blue Capital Inc bought 1,068 Pfizer shares in Q1 2026, an estimated $28.4K.
  • Pfizer made up 0.18% of Blue Capital Inc's portfolio in Q1 2026, its #88 holding.
  • Blue Capital Inc first reported a position in Pfizer in Q4 2024 and has held it in 3 quarters since.
  • Blue Capital Inc's Pfizer position peaked at $595K in Q4 2024.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Blue Capital Inc's 13F filing for Q1 2026, filed 24 Apr 2026.